Search results
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
Zacks via Yahoo Finance· 6 days agoMerck's (MRK) acquisition of EyeBio is set to add the latter's lead pipeline candidate, Restoret, a...
Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly
Simply Wall St. via Yahoo Finance· 4 days agoWhen we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We can see that Merck & Co.
Summit Therapeutics stock rallies as institutional buyer loads up on shares | Invezz
Invezz· 2 days agoSummit Therapeutics Inc (NASDAQ: SMMT) says it raised $200 million via an offer it accepted from an...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga· 2 days agoMonday, Moderna Inc MRNA and Merck & Co Inc MRK announced the first presentation of results from a planned analysis from the Phase 2b KEYNOTE-942/mRNA-4157 ...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga· 1 day agoOn Friday, Pfizer Inc PFE revealed its drug for an advanced form of lung cancer showed promising...
Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus...
Benzinga via Yahoo Finance· 5 days agoOn Friday, Summit Therapeutics Inc (NASDAQ:SMMT) shares are trading lower after the company’s stock...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 2 days ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
Summit Shares Soar After Cancer Drug Tops Merck’s Keytruda
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage...
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 6 days agojumped more than 270% Thursday after the company said its experimental cancer drug outperformed ...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 2 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...